The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The In Vitro Diagnostics Market From 2026 To 2030?
The in vitro diagnostics market has witnessed substantial growth over recent years. Its valuation is projected to rise from $136.55 billion in 2025 to $152.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. This historical expansion can be primarily linked to an increase in diagnostic testing volumes, more extensive screening for infectious diseases, the escalating burden of chronic illnesses, advancements in laboratory infrastructure, and improved access to healthcare.
The in vitro diagnostics market is set to experience swift expansion in the upcoming years. It is forecast to reach $241.14 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2%. This projected increase can be attributed to the rising adoption of decentralized diagnostics, increased investments in molecular testing technologies, the broadening of personalized medicine diagnostics, a surging demand for rapid and accurate testing, and the expanding integration of ai-driven diagnostics. Notable trends during this period encompass the greater embrace of point-of-care diagnostic devices, an elevated demand for molecular and immunoassay testing, the increasing utilization of automated laboratory systems, the proliferation of multiplex diagnostic platforms, and an intensified focus on rapid testing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp
What Significant Factors Are Influencing The In Vitro Diagnostics Market Expansion?
The rising prevalence of cancer is expected to significantly drive the expansion of the in vitro diagnostics market. Cancer refers to a wide array of over 100 distinct diseases that can develop in numerous locations throughout the body. The increasing occurrence of cancer can be attributed to evolving lifestyle choices, including heightened tobacco use, insufficient diet, physical inactivity, and environmental pollution, factors that collectively increase cancer risk across populations. In vitro diagnostics (IVDs) encompass a category of tests or medical devices that examine samples taken from the human body, providing essential information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, the United States is projected to experience 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Therefore, the expanding incidence of cancer is anticipated to fuel the growth of the in vitro diagnostics market.
What Are The Main Segments Within The In Vitro Diagnostics Market Segment Structure?
The in vitro diagnostics market covered in this report is segmented –
1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By Type of Expenditure: Public, Private
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
Subsegments:
1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing
2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)
3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing
4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices
5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems
6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers
7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters
8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers
What Trends Are Affecting The Direction Of The In Vitro Diagnostics Market?
Leading companies in the in vitro diagnostics market are embracing advanced technologies, such as UIMG image technology and 2D decoder chips, to elevate the precision and efficiency of diagnostic tests, refine data analysis, streamline operational procedures, and ultimately achieve superior patient outcomes. UIMG image technology is a sophisticated imaging technique utilized in diagnostics for capturing and analyzing high-resolution images, thereby improving the visualization and interpretation of biological samples. For example, in November 2023, Newland, an EMEA, Netherlands-based technology company, unveiled its IVD (in vitro diagnostics) product line. This new IVD product line features five barcode scanners that are compact, robust, and optimized for automated diagnostic processes. These scanners are designed to enhance the speed and accuracy of diagnostics, which is essential given the rising demand for efficient healthcare solutions.
Who Are The Companies Participating In The In Vitro Diagnostics Market?
Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.
Get The Full In Vitro Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Which Region Leads The In Vitro Diagnostics Market In Terms Of Market Share?
North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In Vitro Diagnostics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company
In Vitro Diagnostics Ivd Quality Control Market Report 2026
In Vitro Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report
In Vitro Diagnostics Enzymes Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model